Enhancer ID: | E_01_0348 |
Species: | human |
Position : | chr17:72118256-72120256 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | -- |
Pubmed ID: | 30552336 |
Enhancer experiment: | PCR?ChIP-seq |
Enhancer experiment description: | In a recent independent but complementary study on Sox9 regulation in the mouse by Gonen and colleagues, an orthologous mouse enhancer (Enh13) showing 80% sequence conservation with eSR-A was identified13 . |
Target gene : | -- |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | In a recent independent but complementary study on Sox9 regulation in the mouse by Gonen and colleagues, an orthologous mouse enhancer (Enh13) showing 80% sequence conservation with eSR-A was identified13 . |
TF name : | SOX9(CMD1,CMPD1,SRA1,SRXX2,SRXY10) |
TF experiment: | PCR?ChIP-seq |
TF experiment description: | In a recent independent but complementary study on Sox9 regulation in the mouse by Gonen and colleagues, an orthologous mouse enhancer (Enh13) showing 80% sequence conservation with eSR-A was identified13 . |
Enhancer function : | In a recent independent but complementary study on Sox9 regulation in the mouse by Gonen and colleagues, an orthologous mouse enhancer (Enh13) showing 80% sequence conservation with eSR-A was identified13 . |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
In a recent independent but complementary study on Sox9 regulation in the mouse by Gonen and colleagues, an orthologous mouse enhancer (Enh13) showing 80% sequence conservation with eSR-A was identified13 . |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|---|---|---|
SOX9 | Deactivation of the beta-catenin transactivating complex | reactome | 42 |
SOX9 | TGF_beta_Receptor | netpath | 220 |
SOX9 | Hs_Neural_Crest_Differentiation_WP2064_79263 | wikipathways | 40 |
SOX9 | Hs_Spinal_Cord_Injury_WP2431_87678 | wikipathways | 21 |